The NIH has given the go signal for an experimental Zika virus vaccine trial that will make use of a DNA vaccine of the virus.
The experimental vaccine is being developed by two London companies who are looking for 60 volunteers to start the clinical trials. The Phase 1 clinical trial is expected to be complete by summer 2018.
A multi-year research funded by the National Institutes of Health has now begun to determine whether a vitamin D supplement can prevent or delay type 2 diabetes.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.